Charles Easley’s work offers hope for couples struggling with the condition.The post Professor seeks solutions to a rise of male infertility appeared first on UGA Today.
The National Institutes of Health has selected Tulane National Primate Research Center to lead a new partnership between the seven federally funded National Primate Research Centers to combine their efforts to accelerate promising COVID-19 vaccine and drug research.
The NIH contract, awarded at $1.7 million for the first year, has the potential to reach up to $6.5 million over a four-year funding period.
Tulane will play a leading role in coordinating the evaluation of promising COVID-19 vaccines and therapeutics for COVTEN (Coronavirus Vaccine and Therapeutic Evaluation Network). The partnership will standardize research protocols and methods of data collection, share preliminary data and best practices across centers, and minimize the use of nonhuman primates by having single control groups across multiple studies. The centers, which normally conduct research independently, aim to harmonize their studies to provide more useful comparative data.
Tulane University to lead national research partnership to speed up COVID-19 vaccine discoveries A COVID-19 researcher in the biosafety level 3 laboratory at the Tulane National Primate Research Center. (Source: Tulane University) By Nicole Mumphrey | February 3, 2021 at 1:55 PM CST - Updated February 3 at 1:56 PM
NEW ORLEANS (WVUE) -The National Institutes of Health has selected Tulane National Primate Research Center to lead a new partnership between the seven federally funded National Primate Research Centers to combine their efforts to accelerate promising COVID-19 vaccine and drug research.
The NIH contract, awarded at $1.7 million for the first year, has the potential to reach up to $6.5 million over a four-year funding period.
T cells have been implicated in the loss of myelin in monkeys with a central nervous system (CNS) disease that is similar to multiple sclerosis (MS) in humans, providing hope that antivirals could be developed as a potential MS treatment.  Conducted by a team from Oregon Health and Science University (OSHU; Portland, OR, USA) and published in the Annals of Clinical and Translational Neurology, the study aimed to probe further into the chance discovery of a naturally occurring disease called Japanese macaque encephalomyelitis in a group of Japanese macaques at the Oregon National Primate Research Center in 2011. If the cause and progression of the.